Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI) (Q33347560)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 1, 2003
edit
Language Label Description Also known as
English
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)
scientific article published on May 1, 2003

    Statements

    Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI) (English)
    Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit